reviewTop 1% cited
The ErbB receptors and their role in cancer progression
Experimental Cell Research · 2003 · Vol. 284(1) · pp. 99–110
Thomas Holbro✉(Friedrich Miescher Institute)
HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchToxin Mechanisms and ImmunotoxinsBiologyErbBReceptorReceptor tyrosine kinaseCancer researchReceptor Protein-Tyrosine KinasesEPH receptor A2Cell biologySignal transductionAngiogenesis
MeSH terms
AnimalsHumansLigandsNeoplasmsSignal TransductionDisease ProgressionReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesDimerizationReceptor, ErbB-3
Citations
611
FWCI
20.97
field-weighted impact
References
142
Percentile
100%
vs. same field & year
Citations per year
Cited by
Insight into nanoparticle cellular uptake and intracellular targeting
Journal of Controlled Release · 2014 · 756 citations
References
Hypoxia — a key regulatory factor in tumour growth
Nature reviews. Cancer · 2002 · 5,147 citations
Untangling the ErbB signalling network
Nature Reviews Molecular Cell Biology · 2001 · 6,890 citations
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer
Human Pathology · 1992 · 409 citations
Epidermal growth factor receptors: critical mediators of multiple receptor pathways
Current Opinion in Cell Biology · 1999 · 607 citations
The Hallmarks of Cancer
Cell · 2000 · 28,385 citations
Regulation of tyrosine kinase cascades by G-protein-coupled receptors
Current Opinion in Cell Biology · 1999 · 690 citations
ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
The EMBO Journal · 1997 · 1,569 citations
EGFR and cancer prognosis
European Journal of Cancer · 2001 · 2,135 citations
Related articles
The ErbB receptors and their role in cancer progression
Experimental Cell Research · 2003 · 611 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.